Board of Directors 2020-2021
Jens Grueger, PhD
Director and Partner
Boston Consulting Group
Zurich, Switzerland
Nancy J. Devlin, PhD
Director, Centre for Health Policy
University of Melbourne
Melbourne Victoria, Australia
Isao Kamae, DrPH, MD,
Project Professor, Health Policy and Technology Assessment, University of Tokyo, Graduate School of Public Policy
Tokyo, Japan
Jalpa A. Doshi, PhD
Professor of Medicine, University of Pennsylvania
Philadelphia, PA, USA
Director (2020-2023)
Eberechukwu Onukwugha, PhD
Associate Professor, University of Maryland
Baltimore, MD, USA
Director (2018-2021)
Rok Hren, PhD, MSc
Head of Laboratory Diagnostics, Point.of.Care and Molecular Diagnostics - Adriatic Region
Siemens Healthineers
Ljubljana, Slovenia
Director (2020-2023)
Kalipso Chalkidou MD, PhD
Director of Global Health Policy, Centre for Global Development
London, UK
Director (2018-2021)
Neil Hawkins, MSc, MBA, PhD
Professor of Health Technology Assessment
University of Glasgow
Scotland, UK
Director (2020-2023)
David Thompson, PhD
Senior Vice President, Real World Evidence, Syneos Health
Manchester, MA, USA
Director (2018-2021)
Raoh-Fang (Jasmine) Pwu, PhD
Director, National Hepatitis C Program Office
Ministry of Health and Welfare
Taipei, Taiwan
Treasurer (2020-2023)
Sean D. Sullivan, BScPharm, MSc, PhD,
Professor and Dean, University of Washington, School of Pharmacy
CEO & Executive Director
Nancy S. Berg
CEO & Executive Director
ISPOR-The Professional Society for Health Economics and Outcomes Research
Lawrenceville, NJ, USA